Innovating Care for Chronic Respiratory Diseases: Targeting IL-33 and Epithelial Alarmins
Join us in-person or online for this CME symposium held as part of the
CHEST 2025 Conference
Breakfast will be served for in-person attendees.
Monday, October 20, 2025
6-6:30 a.m. (CDT): Check in and Breakfast
6:30-7:30 a.m. (CDT): Educational Program
Marriott Marquis Chicago
Great Lakes Ballroom ABC
2121 S Prairie Ave, Chicago, IL 60616
Add event to calendar
Recent studies have emphasized the role of epithelial alarmins—particularly IL-33—in driving immune responses and exacerbations in chronic respiratory diseases such as asthma, COPD, and acute viral respiratory infections. IL-33 stands out due to its dual role in type-2 immune responses and antiviral defense mechanisms. IL-33 not only amplifies inflammation during viral infections like influenza and SARS-CoV-2 but also contributes to chronic airway remodeling and dysfunction. Understanding the interactions among IL-33, IL-25, and TSLP can unlock novel insights into respiratory disease pathophysiology and inform innovative therapeutic strategies.
This CME breakfast symposium, presented by National Jewish Health, will bring together leading pulmonologists, allergists/immunologists, and critical care specialists for a moderated panel to explore multidisciplinary perspectives on IL-33 and other epithelial alarmins in respiratory disease management. The panel will discuss real-world clinical cases to deepen attendees’ understanding of respiratory pathophysiology and guide the application of evidence-based strategies to personalize patient care.
Target Audience:
Pulmonologists, Allergists/Immunologists, Critical Care Specialists, Nurse Practitioners and Physician Assistants in those specialties.
Program Faculty:
Reilley Chair of Lung Injury, Repair and Interstitial Disease
Professor of Medicine
Section Head for Critical Care
Associate Vice President for Academic Affairs
National Jewish Health
Denver, CO
Rohit Katial, MD, FAAAAI, FACAAI, FACP
Professor of Medicine
Associate Vice President of Education
Director, Center for Clinical Immunology
Irene J. & Dr. Abraham E. Goldminz,
Chair in Immunology and Respiratory Medicine
National Jewish Health
Denver, CO
System Chair, Samuel Bronfman Department of Medicine
Murray M. Rosenberg Professor of Medicine
Icahn School of Medicine at Mount Sinai
Mount Sinai Health System
New York, NY
Katharine M. Woessner, MD, FAAAAI
Clinical Professor of Medicine
Division Head Allergy, Asthma and Immunology
Scripps Health
San Diego, CA
Accreditation and Designation Statements:
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
National Jewish Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Contact:
For questions, please call the Office of Professional Education at National Jewish Health at 303.398.1000 or 800.844.2305, or email ProEd@njhealth.org.
Support:
This activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals.
Registration Information:
If interested in attending, please register below. This CME symposium is complimentary for both in-person and livestream attendees.
In-Person:
- In-person attendees must be registered as part of the CHEST 2025 Conference to attend this event.
- In-person attendees may begin arriving at 6 a.m. for check-in and breakfast.
- Please arrive early, as seating and food may be limited.
Online:
- Online attendees do not need to be registered as part of the CHEST 2025 Conference to attend this online event.
- Online attendees will receive the link to view the live symposium in a confirmation email.
Add event to calendar